Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Neuroscience Letters
|
August 28, 2019
Neuropathic pain in individuals with sickle cell disease
Deva Sharma, Amanda M Brandow
Hematology. American Society of Hematology. Education Program
|
December 7, 2024
Beyond IV push: alternative methods for management of acute pain in SCD
Melissa Azul, Amanda M Brandow
Clinical Pediatric Emergency Medicine
|
September 20, 2011
"Sickle Cell Disease in the Emergency Department: Atypical Complications and Management"
Amanda M Brandow, Robert Liem
Hematology. American Society of Hematology. Education Program
|
December 10, 2017
Responsiveness of Patient-Reported Outcome Measurement Information System (PROMIS) pain domains and disease-specific patient-reported outcome measures in children and adults with sickle cell disease
Susanna Curtis, Amanda M Brandow
Hematology. American Society of Hematology. Education Program
|
December 4, 2020
Neuropathic pain in sickle cell disease: measurement and management
Alexander Glaros, Amanda M Brandow
Pediatric Clinics of North America
|
November 9, 2025
The Pediatric Clinician's Evidence-based Strategies for Anticipatory Management and Treatment of Acute Pain at Home for Children and Adolescents with Sickle Cell Disease
Melissa Azul, Amanda M Brandow
Journal of Pediatric Hematology/Oncology
|
February 25, 2016
Clinical Interpretation of Quantitative Sensory Testing as a Measure of Pain Sensitivity in Patients With Sickle Cell Disease
Amanda M Brandow, Julie A Panepinto
Hematology/Oncology Clinics of North America
|
May 7, 2018
Key Components of Pain Management for Children and Adults with Sickle Cell Disease
Amanda M Brandow, Michael R DeBaun
American Journal of Hematology
|
August 5, 2011
Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease
Amanda M Brandow, Julie A Panepinto
Expert Review of Hematology
|
November 19, 2010
Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities
Amanda M Brandow, Julie A Panepinto
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Neuroscience Letters
|
August 28, 2019
Neuropathic pain in individuals with sickle cell disease
Deva Sharma, Amanda M Brandow
Hematology. American Society of Hematology. Education Program
|
December 7, 2024
Beyond IV push: alternative methods for management of acute pain in SCD
Melissa Azul, Amanda M Brandow
Clinical Pediatric Emergency Medicine
|
September 20, 2011
"Sickle Cell Disease in the Emergency Department: Atypical Complications and Management"
Amanda M Brandow, Robert Liem
Hematology. American Society of Hematology. Education Program
|
December 10, 2017
Responsiveness of Patient-Reported Outcome Measurement Information System (PROMIS) pain domains and disease-specific patient-reported outcome measures in children and adults with sickle cell disease
Susanna Curtis, Amanda M Brandow
Hematology. American Society of Hematology. Education Program
|
December 4, 2020
Neuropathic pain in sickle cell disease: measurement and management
Alexander Glaros, Amanda M Brandow
Pediatric Clinics of North America
|
November 9, 2025
The Pediatric Clinician's Evidence-based Strategies for Anticipatory Management and Treatment of Acute Pain at Home for Children and Adolescents with Sickle Cell Disease
Melissa Azul, Amanda M Brandow
Journal of Pediatric Hematology/Oncology
|
February 25, 2016
Clinical Interpretation of Quantitative Sensory Testing as a Measure of Pain Sensitivity in Patients With Sickle Cell Disease
Amanda M Brandow, Julie A Panepinto
Hematology/Oncology Clinics of North America
|
May 7, 2018
Key Components of Pain Management for Children and Adults with Sickle Cell Disease
Amanda M Brandow, Michael R DeBaun
American Journal of Hematology
|
August 5, 2011
Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease
Amanda M Brandow, Julie A Panepinto
Expert Review of Hematology
|
November 19, 2010
Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities
Amanda M Brandow, Julie A Panepinto
Page
of 8